Budesonide/formoterol

Budesonide/formoterol is a combination formulation containing budesonide and formoterol used in the management of asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients delivered via a single inhaler:

The formulation is marketed under various trade names, notably by AstraZeneca under the trade name Symbicort and others.